Cramer Says Oracle “Going Down,” Here’s What He’d Buy
Jim Cramer tells CNBC’s Mad Money Investing Club to sell Oracle and avoid liquor stocks, outlining a mix of defensive...
Which Cash Back Credit Card Is Right For Me
Determine which cash back credit card suits you best. Understand your spending habits to choose the right card for maximum rewards.
26,137 articles
Luxury Operator Draws Million: Big Fund Bet on Premium Gyms
A premium fitness brand attracts a substantial fund investment while its stock lags. This piece breaks down what it m...
Anthropic (Claude) Only Trillion IPO Worth Buying Now
The AI race is heating up, and anthropic (claude) only trillion is a headline that won’t fade. This article breaks do...
Massive News PayPal Stock: What Investors Should Do
A wave of headlines around massive news PayPal stock has investors scanning the market for clues. This article breaks...
Can Rivian Disrupt Market Reward for Investors in 2026
As Rivian pivots toward the R2 and scalable production, investors wonder if the company can disrupt market reward in ...
SpaceX Live Wall Street’s Hype Meets Reality Check
Investors are weighing a megadeal gamble as SpaceX mulls a public listing. Analysts warn that the moonshot rhetoric m...
Prediction: Inflation Data Will Re-Take Center Stage After Oil Spike
When oil surges grab the headlines, it’s easy to assume inflation will follow. In reality, inflation data often reass...
Parabilis Soared Biggest Biotech: Is It Too Late to Buy?
A record biotech IPO backdrop has investors buzzing about Parabilis Medicines. This guide breaks down what the surge ...
Serenity Capital Management Opens a New Mattel Position
A discreet fund quietly builds a Mattel stake, signaling conviction or a calculated thesis. This article breaks down ...
Archer Aviation Could Double as FAA Certification Nears
Archer Aviation advances toward FAA Type Certification, with a looming Texas governance vote and a quarterly report t...
Nebius Stock Popped Today After Meta Deal Boost Surge
When a tech giant inks a massive AI deal, stock moves follow. This analysis explains why neb ius stock popped today, ...
Biotech Takeover Targets Wall Street Eyes After Apogee Deal
AbbVie’s Apogee deal has revived takeover chatter. Three Nasdaq-listed biotech players are emerging as plausible biot...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status